GENE ONLINE|News &
Opinion
Blog

2021-06-18| ChinaPolicySpecial

From Great Challenges to Great Opportunities: An Outlook on US-China Biotech Relationships

by Daniel Ojeda
Share To
The US-China relationship is under a lot of stress following a trade war and a global pandemic. For companies, these are crucial markets that offer great opportunities but also great challenges.
During the BIO Digital 2021, a panel of policy experts discussed their opinions and views on how the US-China relationships will affect biotechnology companies in 2021. 

GO Prime with only $1.49 now

LATEST
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
Scientists Identify New Genetic Variant Related to Obesity
2022-12-01
Micronbrane Medical Aspires to Further Clinical Collaboration Following the Successful Series A Funding
2022-12-01
FDA Revokes Authorization Of Eli Lilly’s COVID-19 Antibody
2022-12-01
Eisai Unveils Lecanemab Data Following Reports of Second Alzheimer’s Patient Death
2022-11-30
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
2022-11-30
Gland Pharma Dispels Rumors Of Fosun Sale, Acquires Cenexi In Separate Development
2022-11-30
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!